Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
Saved in:
| Main Authors: | Florine E. M. Scholte, Jessica R. Spengler, Stephen R. Welch, Jessica R. Harmon, JoAnn D. Coleman-McCray, Brendan T. Freitas, Markus H. Kainulainen, Scott D. Pegan, Stuart T. Nichol, Éric Bergeron, Christina F. Spiropoulou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | Emerging Microbes and Infections |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2019.1601030 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammation associated with monocyte/macrophage activation and recruitment corresponds with lethal outcome in a mouse model of Crimean-Congo haemorrhagic fever
by: Teresa E. Sorvillo, et al.
Published: (2024-12-01) -
Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral speciesResearch in context
by: Stephen R. Welch, et al.
Published: (2025-09-01) -
Rapid, sensitive, and species-independent detection of Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 antibodiesResearch in context
by: Elif Karaaslan, et al.
Published: (2025-08-01) -
Clinical and laboratory features of the course of the Crimean-Congo hemorrhagic fever in Uzbekistan
by: S. S. Saydaliev, et al.
Published: (2022-07-01) -
The world areal of Crimean-Congo hemorrhagic fever virus
by: S. Ye. Smirnova
Published: (2006-12-01)